01.12.2011 | Research Articles
Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain
Erschienen in: Clinical and Translational Oncology | Ausgabe 12/2011
Einloggen, um Zugang zu erhalten